Many life sciences organizations are faced with the promise of great discoveries and the challenges of market fluctuations and increasing regulation. For pharmaceutical, biotechnology, medical products, and technology and device companies, the life sciences industry is changing at an unprecedented rate. These organizations face a host of issues: the impact of managed care, new therapeutic discoveries, revolution in research and development and drug discovery, securing patents and intellectual property protection, evolution of the biotech sector, emergence of the specialty and generic sectors, access to capital, royalty and revenue recovery, mergers and acquisitions, shifting markets and sources, worldwide efforts to control health care costs, and an evolving regulatory and compliance environment.

Our Life Sciences practice can help you respond to market forces and increase your possibilities by addressing these and other challenges in today's complex environment.  We work with our clients on many issues, including:

• Auditing and Assurance
• Strategic Alliances and Collaborations
• Corporate Governance, Internal Control and Sarbanes-Oxley Accountability
• Food and Drug Administration, Regulatory, Clinical Trials and Office of Inspector General Compliance
• Rebate and Pricing Strategy and Compliance
• Intellectual Property Protection
• Tax Jurisdictional Strategies & Compliance
• Technology Solutions and Implementation
• And more…

John Rhodes, Deloitte & Touche LLP's global managing partner of Life Sciences, offers insights on the issues most vital to the industry today.